4//SEC Filing
ROYSTON IVOR 4
Accession 0001209191-23-047671
CIK 0001061027other
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 6:52 PM ET
Size
8.5 KB
Accession
0001209191-23-047671
Insider Transaction Report
Form 4
ROYSTON IVOR
DirectorCEO & President
Transactions
- Exercise/Conversion
Restricted Stock Units
2023-08-25−25,219→ 176,533 total→ Common Stock (25,219 underlying) - Exercise/Conversion
Common Stock
2023-08-25+25,219→ 713,646 total
Holdings
- 18,599(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Viracta Therapeutics, Inc. Common Stock.
- [F2]One-eighth (1/8th ) of the RSU Award will vest on November 25, 2021 (the "First Vesting Date"), and one-sixteenth (1/16th ) of the RSU Award will vest each Quarterly Vesting Date (as defined below) after the First Vesting Date, in each case subject to the reporting person continuing to be a Service Provider (as defined in the Viracta Subsidiary, Inc. 2016 Equity Incentive Plan, the "Plan") through the applicable vesting date. For the purposes of the foregoing, "Quarterly Vesting Date" means February 25, May 25, August 25,and November 25 of each year.
Documents
Issuer
Viracta Therapeutics, Inc.
CIK 0001061027
Entity typeother
Related Parties
1- filerCIK 0001026765
Filing Metadata
- Form type
- 4
- Filed
- Aug 28, 8:00 PM ET
- Accepted
- Aug 29, 6:52 PM ET
- Size
- 8.5 KB